AAAAAA
Results:
1-16
|
Results: 16
Authors:
Saiman, L
LaRussa, P
Steinberg, SP
Zhou, J
Baron, K
Whittier, S
Della-Latta, P
Gershon, AA
Citation: L. Saiman et al., Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers, INFECT CONT, 22(5), 2001, pp. 279-283
Authors:
Gershon, AA
Citation: Aa. Gershon, Live-attenuated varicella vaccine, INF DIS CL, 15(1), 2001, pp. 65
Authors:
LaRussa, P
Gershon, AA
Citation: P. Larussa et Aa. Gershon, Disseminated rashes and varicella vaccine - Reply, PEDIAT INF, 20(4), 2001, pp. 468-468
Authors:
Vazquez, M
LaRussa, PS
Gershon, AA
Steinberg, SP
Freudigman, K
Shapiro, ED
Citation: M. Vazquez et al., The effectiveness of the varicella vaccine in clinical practice, N ENG J MED, 344(13), 2001, pp. 955-960
Authors:
Wang, ZH
Gershon, MD
Lungu, O
Zhu, ZL
Mallory, S
Arvin, AM
Gershon, AA
Citation: Zh. Wang et al., Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: Interactions ofglycoproteins with tegument, J VIROLOGY, 75(1), 2001, pp. 323-340
Authors:
Levin, MJ
Gershon, AA
Weinberg, A
Blanchard, S
Nowak, B
Palumbo, P
Chan, CY
Citation: Mj. Levin et al., Immunization of HIV infected children with varicella vaccine, J PEDIAT, 139(2), 2001, pp. 305-310
Authors:
LaRussa, P
Steinberg, SP
Shapiro, E
Vazquez, M
Gershon, AA
Citation: P. Larussa et al., Varicella vaccine revisited, NAT MED, 6(12), 2000, pp. 1299-1299
Authors:
Gershon, AA
Citation: Aa. Gershon, The varicella vaccine: From promise to practice, INF DIS C P, 9(6), 2000, pp. 253-256
Authors:
Gershon, AA
Rudnick, J
Kalam, L
Zimmerman, K
Citation: Aa. Gershon et al., The homeodomain-containing gene Xdbx inhibits neuronal differentiation in the developing embryo, DEVELOPMENT, 127(13), 2000, pp. 2945-2954
Authors:
Larussa, P
Steinberg, SP
Shapiro, E
Vazquez, M
Gershon, AA
Citation: P. Larussa et al., Viral strain identification in varicella vaccinees with disseminated rashes, PEDIAT INF, 19(11), 2000, pp. 1037-1039
Authors:
Sharrar, RG
LaRussa, P
Galea, SA
Steinberg, SP
Sweet, AR
Keatley, RM
Wells, ME
Stephenson, WP
Gershon, AA
Citation: Rg. Sharrar et al., The postmarketing safety profile of varicella vaccine, VACCINE, 19(7-8), 2000, pp. 916-923
Authors:
Gershon, AA
Citation: Aa. Gershon, Live attenuated varicella vaccine, CONTR ONCOL, 55, 2000, pp. 286-304
Authors:
Gershon, AA
Perkin, RT
Citation: Aa. Gershon et Rt. Perkin, Herpes zoster, N ENG J MED, 343(3), 2000, pp. 222-222
Authors:
Annunziato, PW
Lungu, O
Panagiotidis, C
Zhang, JH
Silvers, DN
Gershon, AA
Silverstein, SJ
Citation: Pw. Annunziato et al., Varicella-zoster virus proteins in skin lesions: Implications for a novel role of ORF29p in chickenpox, J VIROLOGY, 74(4), 2000, pp. 2005-2010
Authors:
Wang, ZH
Gershon, MD
Lungu, O
Zhu, ZL
Gershon, AA
Citation: Zh. Wang et al., Trafficking of varicella-zoster virus glycoprotein gI: T-338-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain, J VIROLOGY, 74(14), 2000, pp. 6600-6613
Authors:
Kohl, S
Rapp, J
La Russa, P
Gershon, AA
Steinberg, SP
Citation: S. Kohl et al., Natural varicella-zoster virus reactivation shortly after varicella immunization in a child, PEDIAT INF, 18(12), 1999, pp. 1112-1113
Risultati:
1-16
|